Novavax, Inc. ( NVAX) - Key Metrics
NVAX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.91 | $0.11 | -$0.24 | -$0.26 |
| 2025Q3 | $0.43 | -$1.25 | $0.66 | $0.65 |
| 2025Q2 | $1.48 | $0.66 | -$0.79 | -$0.79 |
| 2025Q1 | $4.14 | $3.22 | -$1.15 | -$1.16 |
NVAX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | 15.53 |
| 2025Q3 | ? | -1.74 |
| 2025Q2 | ? | 2.40 |
| 2025Q1 | ? | 0.50 |
NVAX
Price: $9.19
52 week price:
Earnings Per Share: -0.56 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 6.6 million
Ebitda: -37.6 millionMarket Capitalization: 1.7 billion